Showing results (221-230 of 319) with videos related to

Sort By:
Pageof 32
Future Oncology (London, England)|May 26, 2022
PD-L1 expression and overall survival in Asian and western patients with gastric cancerSun Young Rha, Geoffrey Y Ku, Hyo Song Kim, et al.
The Lancet. Oncology|April 19, 2013
Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trialFlorian Lordick, Yoon-Koo Kang, Hyun-Cheol Chung, et al.
Oncology|November 18, 2014
Clinicopathological features and prognostic significance of HER2 expression in gastric cancerJi Soo Park, Sun Young Rha, Hyun Cheol Chung, et al.
Clinical Chemistry|October 28, 2022
Analytical and Clinical Validation of Cell-Free Circulating Tumor DNA Assay for the Estimation of Tumor Mutational BurdenKwang Seob Lee, Jieun Seo, Choong-Kun Lee, et al.
Japanese Journal of Clinical Oncology|December 19, 2022
Pembrolizumab or pembrolizumab plus chemotherapy versus standard of care chemotherapy in patients with advanced gastric or gastroesophageal junction adenocarcinoma: Asian subgroup analysis of KEYNOTE-062Hironaga Satake, Keun-Wook Lee, Hyun Cheol Chung, et al.
Journal of Global Oncology|August 8, 2018
Ramucirumab Safety in East Asian Patients: A Meta-Analysis of Six Global, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical TrialsChia-Jui Yen, Kei Muro, Tae-Won Kim, et al.
Investigational New Drugs|February 28, 2014
A phase II open-label randomized multicenter trial of TSU-68 in combination with S-1 and oxaliplatin versus S-1 in combination with oxaliplatin in patients with metastatic colorectal cancerJeeyun Lee, Sang Joon Shin, Ik Joo Chung, et al.
European Journal of Cancer (Oxford, England : 1990)|March 11, 2025
Efficacy and safety of larotrectinib in patients with TRK fusion gastrointestinal cancerChangsong Qi, Lin Shen, Thierry Andre, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 10, 2010
Phase II study of preoperative chemoradiotherapy (CRT) with irinotecan plus S-1 in locally advanced rectal cancerSang Joon Shin, Nam Kyu Kim, Ki Chang Keum, et al.
Cancer|July 20, 2024
Lenvatinib plus pembrolizumab for patients with previously treated, advanced, triple-negative breast cancer: Results from the triple-negative breast cancer cohort of the phase 2 LEAP-005 StudyHyun Cheol Chung, Esma Saada-Bouzid, Federico Longo, et al.
Pageof 32